Key result
Transcatheter aortic valve replacement (TAVR) in younger patients requires balancing the initial less invasive benefit with a credible plan for lifelong valve care.
Answers are grounded in this paper and cite their sources.
This editorial discusses the evolving role of TAVR in younger patients, emphasizing the need to balance the benefits of a less invasive initial procedure with a credible plan for lifelong valve care.
In this issue of Structural Heart, Kropp and colleagues provide a timely contribution to the discussion of transcatheter aortic valve replacement (TAVR) in younger patients.1 Their analysis brings the early clinical experience of a large national population into a debate increasingly shaped by long-term considerations. Its value is best appreciated within the cumulative evolution of TAVR, as successive studies refine patient selection and identify opportunities for improvement. For younger patients, the next stage of progress will depend on connecting the benefits of a less invasive initial procedure with a credible plan for lifelong valve care.
No takes yet. Share an insight, caveat, or question.
Giacaman et al. (2026) conducted an editorial in Aortic valve disease. Transcatheter aortic valve replacement (TAVR) was evaluated. Transcatheter aortic valve replacement (TAVR) in younger patients requires balancing the initial less invasive benefit with a credible plan for lifelong valve care.
Synapse has enriched 10 related papers. Consider them for comparative context: